Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2026-01-01 @ 2:27 AM
Study NCT ID:
NCT06806033
Status:
RECRUITING
Last Update Posted:
2025-12-23
First Post:
2025-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-05
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-21
First Submit QC Date:
None
Study First Post Date:
2025-02-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-20
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED